The latest version of GastroPlus®, GPX.2, is designed to change your PBPK/PBBM life. Join us for this webinar and judge for yourself.

You’ll get a first look at game-changing new functionality that will revolutionize your PBPK/PBBM modeling, as well as additional dosage routes.

Our experts will introduce you to…

• ACATPlus™, the extension of the industry-leading ACAT™ model for understanding local drug disposition in the gastrointestinal tract
• AssessmentsPlus™, for efficiently building high-quality PBPK/PBBM models using embedded expert knowledge, including the option to enhance the advice with our finely-tuned large language model (LLM)
• Distribution Dashboard, which provides mechanistic insight into the tissue binding in PBPK tissues and fitting the most relevant input parameter
• Intramuscular and subcutaneous dosing, which have been incorporated into the GPX paradigm
• Orchestrator, for automating GPX.2 workflows as well as extending functionality and plotting via R/Python
• P-PSD™, for fitting dissolution data using a product particle size distribution to represent the surface area of drug substance available for dissolution
• Virtual replicate BE functionality, enhanced to include full and semi-replicate designs commonly used in bioequivalence studies

Attendees will have the opportunity to ask questions live during our Q&A.

This is your chance to see the latest PBPK/PBBM software in action—register now to save your seat!

Presenters:

• Neil Miller – Vice President, PBPK Product Development
• Becky Graves – Senior Director, Scientific Product Enablement

Moderator:

• Peter Kilford – Associate Vice President, Software Business Development